Historical Stock Price
ETFs Holding KALA »    KALA Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
12/02/2022 $5.07 $5.20 $4.95 $5.02 51.70K
12/05/2022 $5.01 $5.07 $4.77 $4.98 82.50K
12/06/2022 $4.97 $4.98 $4.67 $4.91 50.00K
12/07/2022 $4.91 $4.96 $4.70 $4.94 33.50K
12/08/2022 $4.94 $5.24 $4.84 $5.08 32.40K
Kala Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of therapies for diseases of the eye. Co.'s two marketed products are EYSUVIS® (loteprednol etabonate ophthalmic suspension) 0.25%, for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease, and INVELTYS® (loteprednol etabonate ophthalmic suspension) 1%, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Co. is also progressing its pipeline of proprietary programs targeted to address front and back of the eye diseases, including KPI-287 and glucocorticoid receptor modulators.
KALA historical stock prices picture
Kala Pharmaceuticals (KALA) has the following price history information. Looking back at KALA historical stock prices for the last five trading days, on December 02, 2022, KALA opened at $5.07, traded as high as $5.20 and as low as $4.95, and closed at $5.02. Trading volume was a total of 51.70K shares. On December 05, 2022, KALA opened at $5.01, traded as high as $5.07 and as low as $4.77, and closed at $4.98. Trading volume was a total of 82.50K shares. On December 06, 2022, KALA opened at $4.97, traded as high as $4.98 and as low as $4.67, and closed at $4.91. Trading volume was a total of 50.00K shares. On December 07, 2022, KALA opened at $4.91, traded as high as $4.96 and as low as $4.70, and closed at $4.94. Trading volume was a total of 33.50K shares. On December 08, 2022, KALA opened at $4.94, traded as high as $5.24 and as low as $4.84, and closed at $5.08. Trading volume was a total of 32.40K shares.

KALA Historical Stock Prices By Date:

KALA historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Kala Pharmaceuticals shares, starting with a $10,000 purchase of KALA, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/21/2017
End date: 12/08/2022
Start price/share: $955.00
End price/share: $5.08
Dividends collected/share: $0.00
Total return: -99.47%
Average Annual Total Return: -62.17%
Starting investment: $10,000.00
Ending investment: $53.22
Years: 5.39
Date Close
12/02/2022$5.02
12/05/2022$4.98
12/06/2022$4.91
12/07/2022$4.94
12/08/2022$5.08
KALA is categorized under the Healthcare sector; below are some other companies in the same sector:

KALV Historical Stock Prices
KBIO Historical Stock Prices
KBLM Historical Stock Prices
KDMN Historical Stock Prices
KEQU Historical Stock Prices
KERX Historical Stock Prices
KIDS Historical Stock Prices
KIN Historical Stock Prices
KIPS Historical Stock Prices
KITE Historical Stock Prices

Also explore: KALA shares outstanding history

Email EnvelopeFree KALA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

KALA Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.